These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients]. Szulc A, Galińska B, Tarasów E, Walecki J, Dzienis W, Kubas B, Czernikiewicz A. Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370 [Abstract] [Full Text] [Related]
10. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Fukuzako H, Takeuchi K, Hokazono Y, Fukuzako T, Yamada K, Hashiguchi T, Obo Y, Ueyama K, Takigawa M, Fujimoto T. Psychiatry Res; 1995 Nov 10; 61(4):193-200. PubMed ID: 8748464 [Abstract] [Full Text] [Related]
11. Neuronal dysfunction of the frontal lobe in schizophrenia. Pae CU, Choe BY, Joo RH, Lim HK, Kim TS, Yoo SS, Choi BG, Kim JJ, Lee SJ, Lee C, Paik IH, Lee CU. Neuropsychobiology; 2004 Nov 10; 50(3):211-5. PubMed ID: 15365217 [Abstract] [Full Text] [Related]
12. Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients. Molina V, Papiol S, Sanz J, Rosa A, Arias B, Fatjó-Vilas M, Calama J, Hernández AI, Bécker J, Fañanás L. Neuroimage; 2011 May 01; 56(1):45-51. PubMed ID: 21296169 [Abstract] [Full Text] [Related]
13. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics]. Gan JL, Duan HF, Yang JM, Shi ZJ, Zhang DW, Jiang ZK, Gao CY, Wang ZJ. Zhonghua Yi Xue Za Zhi; 2011 Nov 22; 91(43):3034-9. PubMed ID: 22333054 [Abstract] [Full Text] [Related]
14. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia. Strzelecki D, Podgórski M, Kałużyńska O, Gawlik-Kotelnicka O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P. Nutrients; 2015 Oct 22; 7(10):8767-82. PubMed ID: 26506383 [Abstract] [Full Text] [Related]
18. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients]. Başoğlu C, Cetin M, Oner O, Ebrinç S, Semiz UB, Kandilcioğlu H, Silit E, Kizilkaya E. Turk Psikiyatri Derg; 2006 Sep 22; 17(2):85-91. PubMed ID: 16755408 [Abstract] [Full Text] [Related]
19. Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia. Thomas MA, Ke Y, Levitt J, Caplan R, Curran J, Asarnow R, McCracken J. J Magn Reson Imaging; 1998 Sep 22; 8(4):841-6. PubMed ID: 9702885 [Abstract] [Full Text] [Related]
20. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 22; 28(8):1313-22. PubMed ID: 15588758 [Abstract] [Full Text] [Related] Page: [Next] [New Search]